1. Human resource development contributes to the creation of outstanding regenerative medicine products;Nishigaki;Regen Ther,2017
2. Regulatory frameworks for gene and cell therapies in Japan;Maeda;Adv Exp Med Biol,2015
3. Insurance systems and reimbursement concerning research and development of regenerative medicine in Japan;Okada;Regen Med,2017
4. Challenging regeneration to transform medicine;Tsukamoto;Stem Cells Transl Med,2016
5. Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune effector cell-related adverse events;Maus;J Immunother Cancer,2020